---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-079859"
form_type: "8-K"
ticker: "PRPO"
cik: "0001043961"
company_name: "Precipio, Inc."
filed_at: "2025-08-18T23:59:59+00:00"
generated_at: "2026-05-17T11:44:01.543320+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.05
calibrated_materiality_score: 0.05
confidence: "low"
source: SEC EDGAR
---

# Precipio updates investor presentation; no material new financial data

## Summary
- Updated investor presentation posted Aug 18, 2025; supersedes version from June 13, 2022.
- Presentation reiterates focus on AML rapid test and expansion into broader molecular diagnostics market.
- No specific financial guidance or material new disclosures included in the presentation.
- Company emphasizes product development platform and go-to-market strategy through distribution partners.
- Presentation includes forward-looking projections on revenue mix and gross margins but without quantified targets.

## SEC filing metadata
- accession: 0001104659-25-079859
- form_type: 8-K
- ticker: PRPO
- cik: 0001043961
- company_name: Precipio, Inc.
- filed_at: 2025-08-18T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.05
- calibrated_materiality_score: 0.05
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1043961/000110465925079859/0001104659-25-079859-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1043961/000110465925079859/tm2523752d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-079859
- JSON: https://secwatch.observer/filing/0001104659-25-079859.json
- Plain text: https://secwatch.observer/filing/0001104659-25-079859.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.